Rui Daniel Prediger
Overview
Explore the profile of Rui Daniel Prediger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
686
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruver-Martins A, Martinez I, Holla V, de Souza B, da Silva E, Novoa D, et al.
Front Hum Neurosci
. 2025 Mar;
18:1466438.
PMID: 40066073
No abstract available.
2.
Dos Santos E, Pantoja L, Farias S, Pinheiro B, Andrade E, Mendes P, et al.
Biomed Pharmacother
. 2024 Jul;
178:117120.
PMID: 39024836
Linalool-rich Rosewood oil (Aniba rosaeodora Ducke) is a natural compound widely used in perfumery industry. Evidence suggests that linalool exerts antidepressant and anxiolytic effects. Conversely, ethanol binge drinking (i.e., intermittent...
3.
Andriolo I, Longo B, de Melo D, de Souza M, Prediger R, da Silva L
CNS Neurol Disord Drug Targets
. 2024 Mar;
23(11):1371-1391.
PMID: 38500273
Introduction: Multiple illnesses commonly involve both the Central Nervous System (CNS) and the Gastrointestinal Tract (GI) simultaneously. Consistent evidence suggests that neurological disorders impair GI tract function and worsen the...
4.
Sampaio T, Schamne M, Santos J, Ferro M, Miyoshi E, Prediger R
Brain Sci
. 2024 Jan;
14(1).
PMID: 38275520
Parkinson's disease (PD) is a multifactorial disease, with genetic and environmental factors contributing to the disease onset. Classically, PD is a movement disorder characterized by the loss of dopaminergic neurons...
5.
Jacques M, de Souza V, Barbosa F, Faria Santos Canto R, Cristiane Lopes S, Prediger R, et al.
ACS Chem Neurosci
. 2023 Jul;
14(16):2857-2867.
PMID: 37499207
Oxidative glutamate toxicity is regarded as one of the injurious mechanisms associated with ischemic stroke, which represents a major health problem and requires improved pharmacological treatments. We designed and synthesized...
6.
Perdigao J, Teixeira B, Carvalho-da-Silva V, Prediger R, Lima R, Rogez H
Crit Rev Food Sci Nutr
. 2023 Jan;
64(19):6596-6615.
PMID: 36718558
Phenolic compounds (PCs) have neuroprotective effects with potential to prevent or slower the progression of Parkinson's disease (PD). However, whether the PCs neuroprotective effects can be observed under their dietary...
7.
de Oliveira L, Poluceno G, Sampaio T, Constantino L, Costa A, Martins W, et al.
Neurotox Res
. 2022 Nov;
40(6):1924-1936.
PMID: 36441450
Neonatal exposure to general anesthetics has been associated with neurotoxicity and morphologic changes in the developing brain. Isoflurane is a volatile anesthetic widely used in pediatric patients to induce general...
8.
Pinheiro B, Luz D, de Carvalho Cartagenes S, Fernandes L, Farias S, Kobayashi N, et al.
Pharmaceuticals (Basel)
. 2022 Nov;
15(11).
PMID: 36355494
Binge drinking intake is the most common pattern of ethanol consumption by adolescents, which elicits emotional disturbances, mainly anxiety and depressive symptoms, as well as cognitive alterations. Ethanol exposure may...
9.
Franca A, Schamne M, de Souza B, Correa T, da Silva-Santos J, Izidio G, et al.
Behav Neurosci
. 2021 Dec;
136(2):139-148.
PMID: 34914421
Attention Deficit Hyperactivity Disorder (ADHD) is a highly prevalent and disabling disorder that frequently persists into adulthood. Many patients are considered nonresponders to typical pharmacological treatments due to insufficient symptoms'...
10.
Roversi K, Callai-Silva N, Roversi K, Griffith M, Boutopoulos C, Prediger R, et al.
Front Immunol
. 2021 Dec;
12:759679.
PMID: 34868000
Parkinson's disease (PD) is the second most common neurodegenerative disorder, affecting 1-2% of the population aged 65 and over. Additionally, non-motor symptoms such as pain and gastrointestinal dysregulation are also...